GB Sciences, Inc logo — AI-Powered Drug Discovery of Plant-Inspired Biopharma Produc...

GB Sciences, Inc

AI-Powered Drug Discovery of Plant-Inspired Biopharma Products for the Rx Drug Market

Founded 2001 United States Las Vegas, United States 19 employees Post-IPO Equity Total: $2.02M Biotechnology, Health Care +1

General Information

Company Name GB Sciences, Inc
Founded Year 2001
Location United States Las Vegas, United States
Founders / Decision Makers
Team member
Employees 19
Industries Biotechnology, Health Care, Manufacturing
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with GB Sciences, Inc. To contact GB Sciences, Inc, visit gbsciences.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GB Sciences, Inc compare?

A PDF of GB Sciences, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GB Sciences, Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GB Sciences, Inc

GB Sciences, Inc. is a plant-inspired research and biopharmaceutical drug development company founded in 2001. Their mission revolves around creating patented formulations of plant-based, optimized therapeutic mixtures to address a variety of medical conditions. With a focus on Biotechnology, Health Care, and Manufacturing, the company is headquartered in the United States. Their most recent investment of $20.00KPost-IPO Equity was made on 13 January 2016. As an investor, these factors demonstrate their commitment to innovation in the biopharmaceutical industry, offering potential for growth and impact.

Business keywords: biopharmaceutical, drug development, plant-based formulations, therapeutic mixtures, medical conditions, patented formulations, plant science, biomedical research, pharmaceutical industry

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity $20.00K -
13 Jan 2016
Post IPO Equity $2.00M -
05 Jun 2014

GB Sciences, Inc Alternatives & Competitors

View All Alternatives
GB Sciences, Inc vs

The Specialist in CNS Drug Development

Post-IPO Equity
23 employees
Biopharma, Biotechnology
GB Sciences, Inc vs

To make disease-modifying treatments available to patients with serious or life-threatening conditio...

Venture round
8 employees
Biotechnology, Health Care
GB Sciences, Inc vs
Neumora
Neumora United States

Pioneering a new era of medicines for brain diseases

Series B
111 employees
Biotechnology, Health Care

FAQ About GB Sciences, Inc

AI-Powered Drug Discovery of Plant-Inspired Biopharma Products for the Rx Drug Market
GB Sciences, Inc was founded in 2001.
GB Sciences, Inc is headquartered in Las Vegas, United States.
GB Sciences, Inc operates in Biotechnology, Health Care and Manufacturing. Its work centres on biopharmaceutical, drug development, plant-based formulations and therapeutic mixtures.
GB Sciences, Inc has approximately 19 employees.
GB Sciences, Inc has completed 2 funding rounds, raising a total of $2.02M. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to GB Sciences, Inc include Newron Pharmaceuticals SpA, MEDIBIOFARMA SL, Neumora, KeyNeurotek Pharmaceuticals, Flexus Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GB Sciences, Inc and Newron Pharmaceuticals SpA are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GB Sciences, Inc, https://bouncewatch.com/company/gb-sciences-inc, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes